1. Allergan offloads two drugs to secure approval for merger with AbbVie — How the China coronavirus could threaten pharma's ingredient sourcing — AstraZeneca sees good results in gastric cancer and stroke studies — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Going South!

Discussion in 'ARIAD' started by Anonymous, Oct 8, 2013 at 10:48 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Uh oh!
     

  2. Anonymous

    Anonymous Guest

    A little birdie tell you something ?
     
  3. Anonymous

    Anonymous Guest

    Should have stayed at my other company:((((
     
  4. Anonymous

    Anonymous Guest

    I should of went to Onyx
     
  5. Anonymous

    Anonymous Guest

    Should have concentrated more in English class...
     
  6. Anonymous

    Anonymous Guest

    Yay! Interviewing! Get me outta here!
     
  7. Anonymous

    Anonymous Guest

    All Onyx Reps that came on last year will have over $700K W2 this year with options, Ariad, uh, enough said.
     
  8. Anonymous

    Anonymous Guest

    Only $350k
     
  9. Anonymous

    Anonymous Guest

    Know many Onyx reps (Celgene) that negotiated 5000 options. Smart move. Ariad, not so smart move here. Oh well, on to the next one?
     
  10. Anonymous

    Anonymous Guest

    Where to now?
     
  11. Anonymous

    Anonymous Guest

    Anyone have an offer? Or even an interview?
     
  12. Anonymous

    Anonymous Guest

    yep...a few to BI, Incyte, BMS each. Gilead up next
     
  13. Anonymous

    Anonymous Guest

    Fantastic news! Glad things are working out for the better for you guys.
     
  14. Anonymous

    Anonymous Guest

    Phuk 'em!